Method Development for Laser-Diffraction Particle-Size Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Method Development for Laser-Diffraction Particle-Size Analysis
The author examines the process of method development, with reference to ISO 13320:2009 and relevant monographs from the United States and European pharmacopoeias.


Pharmaceutical Technology
pp. 100-106

References

1. ISO 13320:2009 Particle Size Analysis—Laser Diffraction Methods. Part 1: General Principles (2009).

2. USP30–NF25 General Chapter <429>, "Light Diffraction Measurement of Particle Size," pp. 1235–1241.

3. ISO 14488:2007 Particulate materials—Sampling and sample splitting for the determination of particulate properties.

4. Application note MRK373: The Use of Zeta Potential Measurements for Improving Dispersion During Particle Size Measurements, http://www.malvern.com/appnote_particle_size_determination, accessed Sept. 18, 2010.

5. ISO 14887:2000 Sample Preparation—Dispersing procedures for powders in liquids (2000).

6. Ph.Eur. 6.6 General Chapter 2.9.31, "Laser Diffraction Measurement of Particle Size," (EDQM, Strasbourg, France) p. 5103.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here